| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director | Director, 10% Owner
3 companies
Canaan IX L.P. is a 10% Owner at REAL, with reported holdings spanning 3 companies. Recent filings cover 0 purchases and 29 sales. Those positions are worth an estimated $137.5M at current prices.
Canaan IX L.P.'s largest disclosed position is in REAL as 10% Owner, worth about $97.5M.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 29, 2016 | CTMX Cytomx Therapeutics, Inc. | Director | Sell | 22,086 | $11.18 | $247,007.62 | -0.6% | |
| Nov 28, 2016 | CTMX Cytomx Therapeutics, Inc. | Director, 10% Owner | Sell | 38,459 | $11.56 | $444,404.44 | -0.3% | |
| Nov 22, 2016 | CTMX Cytomx Therapeutics, Inc. | Director, 10% Owner | Sell | 42,550 | $11.71 | $498,077.54 | -1.1% | |
| Nov 21, 2016 | CTMX Cytomx Therapeutics, Inc. | Director, 10% Owner | Sell | 45,324 | $11.61 | $526,087.76 | -0.4% | |
| Nov 16, 2016 | CTMX Cytomx Therapeutics, Inc. | Director, 10% Owner | Sell | 51,581 | $11.50 | $593,428.35 | -0.7% | |
| Nov 14, 2016 | CTMX Cytomx Therapeutics, Inc. | Director, 10% Owner | Sell | 86,270 | $11.16 | $962,906.75 | -0.7% | |
| Nov 9, 2016 | CTMX Cytomx Therapeutics, Inc. | Director, 10% Owner | Sell | 13,730 | $11.03 | $151,498.19 | -0.3% | |
| Jun 10, 2016 | CTMX Cytomx Therapeutics, Inc. | Director, 10% Owner | Sell | 48,427 | $10.07 | $487,498.32 | -0.4% | |
| Jun 7, 2016 | CTMX Cytomx Therapeutics, Inc. | Director, 10% Owner | Sell | 111,498 | $10.01 | $1,116,289.60 | -1.3% | |
| Jun 3, 2016 | CTMX Cytomx Therapeutics, Inc. | Director, 10% Owner | Sell | 59,621 | $10.80 | $644,047.71 | -0.7% |